Study on the Asymmetric Synthesis of Chiral 3,3,3‐Trifluoro‐2‐Hydroxypropanoic Acids by Lactate Dehydrogenase
ChemBioChem · 2025
DOI: 10.1002/cbic.202500047 ↗Kurz gefasst
Fachartikel in der Zeitschrift ChemBioChem, 2025. Verfasst von Jingfei Wu und 4 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnology Research Center and Department of Biotechnology, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan. Hauptthemen laut MEDLINE: L-Lactate Dehydrogenase. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Japan Society for Promotion of Sciences, Toyama Pharmaceutical Valley Development Consortium, Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Chiral 3,3,3‐trifluoro‐2‐hydroxypropanoic acid (3,3,3‐trifluorolactic acid, TFLA), which possesses two significant functional groups, is a versatile intermediate in pharmaceutical and material synthesis. A feasible strategy for producing both the enantiomers of chiral TFLAs involves reduction of the corresponding pyruvate using lactate dehydrogenases (LDHs). In this study, ldh genes encoding l ‐LDHs from animals and d / l ‐LDHs from lactic acid bacteria are cloned and all the recombinant LDHs are successfully expressed with a histidine tag in Escherichia coli BL21 (DE3). To achieve cofactor regeneration, a nicotinamide adenine dinucleotide regeneration system is constructed using formate dehydrogenase from Candida boidinii . Chiral TFLA is synthesized from 3,3,3‐trifluoro‐2‐oxopropionic acid (trifluoropyruvic acid, TFPy) with good yields and excellent stereoselectivity, catalyzed by lactate dehydrogenases and formate dehydrogenase. Under optimized biocatalytic conditions, highly active d ‐ Lm LDH from Leuconostoc mesenteroides and chicken l ‐LDH from Gallus are screened for their ability to completely convert 0.5 m TFPy to produce optically pure ( S )‐TFLA and ( R )‐TFLA with enantiomeric excess >99.5% within 6 h, respectively. Molecular docking simulations investigate the catalytic mechanisms of selected d ‐LDH and l ‐LDH, revealing their activity and stereoselectivity toward CF 3 ‐containing TFPy.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Biotechnology Research Center and Department of Biotechnology, Toyama Prefectural University, 5180 Kurokawa, Imizu, Toyama, 939-0398, Japan.
- New-STEP Research Center, Central Glass Co., Ltd., 17-5, Nakadai 2-chome, Kawagoe City, Saitama, 350-1159, Japan.
ORCID-Profile: Jingfei Wu, Aem Nuylert, Yasuhisa Asano
Förderung
- Japan Society for Promotion of Sciences
- Toyama Pharmaceutical Valley Development Consortium
- Japan Society for the Promotion of Science
Zitieren
APA
Wu, J., Nuylert, A., Iwaki, M., Miki, S., & Asano, Y. (2025). Study on the Asymmetric Synthesis of Chiral 3,3,3‐Trifluoro‐2‐Hydroxypropanoic Acids by Lactate Dehydrogenase. ChemBioChem. https://doi.org/10.1002/cbic.202500047
Vancouver
Wu J, Nuylert A, Iwaki M, Miki S, Asano Y. Study on the Asymmetric Synthesis of Chiral 3,3,3‐Trifluoro‐2‐Hydroxypropanoic Acids by Lactate Dehydrogenase. ChemBioChem. 2025. doi:10.1002/cbic.202500047
BibTeX
@article{Wu2025,
author = {Wu, Jingfei and Nuylert, Aem and Iwaki, Misako and Miki, Shinsuke and Asano, Yasuhisa},
title = {Study on the Asymmetric Synthesis of Chiral 3,3,3‐Trifluoro‐2‐Hydroxypropanoic Acids by Lactate Dehydrogenase},
journal = {ChemBioChem},
year = {2025},
doi = {10.1002/cbic.202500047}
}
EUVIMED